Aldesleukin Unknown Status Phase 1 Trials for Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00006100Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma